Diabetic neuropathy. Type 2 diabetes mellitus with diabetic neuropathy, unspecified
Conditions
Interventions
Intervention 1: In the leech treatment group, three to five medical leeches, six to eight centimeters in size, are thrown in three steps every fifteen days in the area of the back of the feet, tangent
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to No maximum
Inclusion criteria
Inclusion criteria: Having informed consent Age 30 years and above Type 2 diabetes with the approval of an endocrinologist Having diabetic neuropathy based on nerve and muscle tape The patient should not use other drugs that are effective on neuropathy at the same time No pregnancy No breastfeeding No other diseases that cause neuropathy such as alcohol, vitamin B12 deficiency, chemotherapy, kidney failure, nerve compression, autoimmune disease, infection, Guillain-Barre syndrome
Exclusion criteria
Exclusion criteria: Having a diabetic foot ulcer requires surgery Use of anticoagulants such as heparin, warfarin, etc Any coagulation disease History of hospitalization due to cardiovascular disease History of major mental disorders Not taking painkillers, or common drugs for neuropathy treatment during the last month Anemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Burning sensation. Timepoint: At the beginning of the study, days 15, 30 and 45 of the beginning of the study. Method of measurement: Using Visual Analogue Scale and Neurophathy Symptom Score questionnaires.;Intensity of pain. Timepoint: At the beginning of the study, days 15, 30 and 45 of the beginning of the study. Method of measurement: Using Visual Analogue Scale and Neurophathy Symptom Score questionnaires.;Tingling. Timepoint: At the beginning of the study, days 15, 30 and 45 of the beginning of the study. Method of measurement: Visual Analogue scale and neuropathy symptom score questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Muscle weakness and cramps. Timepoint: At the beginning of the study, days 15, 30 and 45 after the start of the study. Method of measurement: Neoropathy Symptom Score questionnaire.;Vibration in the big toe. Timepoint: At the beginning of the study, days 15, 30 and 45 after the start of the study. Method of measurement: Neurophathy Disability Score questionnaire.;Recognize the feeling of cold and heat in the back of the legs. Timepoint: At the beginning of the study, days 15, 30 and 45 after the start of the study. Method of measurement: Neurophathy Disability Score questionnaire.;Detect sharp and blunt bodies on the big toe. Timepoint: At the beginning of the study, days 15, 30 and 45 after the start of the study. Method of measurement: Neurophathy Disability Score questionnaire.;Presence or absence of Achilles reflex. Timepoint: At the beginning of the study, days 15, 30 and 45 after the start of the study. Method of measurement: Neurophathy Disabilities score questionnaire.;Possible repair of foot nerves in its treatment with leeches. Timepoint: Before the start of the study and 45 days after the start of the study. Method of measurement: Nerve conduction velocity.;Possible repair of foot nerves in drug treatment. Timepoint: Before the start of the study and 45 days after the start of the study. Method of measurement: Nerve conduction velocity. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarshad Alami
Kerman University of Medical Sciences
Outcome results
None listed